Illustrative image – not actual.Aurobindo Pharma is likely to get an approval from the USFDA for its new facility in Hyderabad.
The inspection for Unit IV facility of the company has already been conducted by USFDA between August and September. This facility is manufacturing injectables. The company is also likely to get clearance for its unit VI, which was facing ban for the past 18 months. The Unit VI manufactures solid dosage formulations.
Source: Economic Times
